Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • News

Ginkgo Bioworks And The Ministry Of Investment Of Saudi Arabia Announce Plans To Develop Biosecurity And Biotechnology Capabilities For Global Public Health

By Benzinga Newsdesk
October 25, 8:59 AM
Collaboration aims to bolster capabilities of key public health and research institutions, launch new biosecurity initiatives, and drive the development of the bioeconomy BOSTON and RIYADH, Saudi

DNA

Read More
1 minute read
  • FDA
  • News

Cutera’s AviClearTM 12-Month Clinical Data Presented At 42nd Annual Fall Clinical Dermatology Conference

By Benzinga Newsdesk
October 25, 8:17 AM
Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that the 12-month clinical data related to AviClear, the first and

CUTR

Read More
1 minute read
  • Events
  • FDA
  • News

Immix Biopharma To Present Milestones Achieved To Enable Kick-Off Of 2 IMX-110 Clinical Trials At 2022 ThinkEquity Conference On October 26

By Benzinga Newsdesk
October 25, 8:15 AM
Immix Biopharma, Inc. (NASDAQ:IMMX) ("ImmixBio", "Company", "We" or "Us"), a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)™ targeting oncology

IMMB

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Small Cap
  • Trading Ideas

GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions

By Vandana Singh
October 25, 7:59 AM
GSK plc (NYSE:GSK) has decided to terminate the License and Collaboration Agreement with Lyell Immunopharma Inc (NASDAQ:LYEL). The termination is effective on December…

GSK

Read More
3 minute read
  • Biotech
  • General

OpGen Subsidiary Curetis And BioVersys Sign Collaboration Agreement For Clinical Trial Support; Unyvero Platform For Rapid Diagnostics To Be Used In Phase Ii Clinical Trial Of BV100

By Benzinga Newsdesk
October 25, 7:31 AM
Unyvero platform for rapid diagnostics to be used in Phase II clinical trial of BV100   Focus on the detection of pneumonia patients infected with Acinetobacter baumannii   ROCKVILLE, Md. and BASEL,

OPGN

Read More
4 minute read
  • Biotech
  • General

Gritstone Highlights Presentation Of Data From CORAL-BOOST Study

By Benzinga Newsdesk
October 25, 7:09 AM
-- New data from CORAL-BOOST study demonstrate broad and durable immune response; high neutralizing antibody and T cell responses at 6 months post-boost vaccination --   -- Interim results from CORAL-CEPI show good

GRTS

Read More
6 minute read
  • Biotech
  • General
  • IPOs
  • News

Avista Public Acquisition Corp. II And OmniAb Business Combination Approved By APAC Shareholders Closing Scheduled for November 1;

By Benzinga Newsdesk
October 24, 5:04 PM
APAC Shareholder Approval Obtained, Closing Scheduled for November 1, 2022 Ligand "Regular Way" and "Ex-Distribution" and OmniAb "When-Issued" Set to Begin Trading on October 25,

AHPA

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • Large Cap
  • News

Biogen Q3 Earnings Preview: Key Items For Investors To Watch

By Vandana Singh
October 24, 2:39 PM
Biogen Inc (NASDAQ: BIIB) is scheduled to report its third-quarter earnings on Tuesday during the premarket session amid cautious hope for its neurodegenerative disease programs and an ongoing

BIIB

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Accelerate Diagnostics Shares Are Plummeting Today?

By Vandana Singh
October 24, 1:52 PM
Accelerate Diagnostics Inc (NASDAQ:AXDX) said that according to recent discussions, the FDA has clarified that the company must obtain a 510(k)…

AXDX

Read More
1 minute read
  • Biotech
  • General
  • News

BioLineRx Has Received A Notice Of Allowance For Its U.S. Patent Application 16/866,588 Titled “Compositions And Methods For Treating Cancer”

By Benzinga Newsdesk
October 24, 1:33 PM
https://patentcenter.uspto.gov/#!/applications/16866588/ifw/docs

BLRX

Posts pagination

Previous 1 … 649 650 651 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service